NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹2.48 Cr | ₹2.19 Cr | ₹1.37 Cr | ₹1.91 Cr | ₹2.38 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NGL FINECHEM ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹2.48 Cr |
| Mar2024 | ₹2.19 Cr |
| Mar2023 | ₹1.37 Cr |
| Mar2022 | ₹1.91 Cr |
| Mar2021 | ₹2.38 Cr |
How is Deferred Tax Assets / Liabilities of NGL FINECHEM Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.48 Cr | 12.85 | |
| Mar2024 | ₹2.19 Cr | 60.15 | |
| Mar2023 | ₹1.37 Cr | -28.20 | |
| Mar2022 | ₹1.91 Cr | -19.76 | |
| Mar2021 | ₹2.38 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,365.5 Cr | 2.3% | -2.8% | 86% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -3.1% | 1.6% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -1.5% | -3.4% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -4.1% | -1.2% | 40.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.5% | -0.9% | 16.8% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -5.7% | -7.8% | -13.2% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 2.3% |
-2.8% |
86% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses